The European Medicines Agency has just released its quarterly data update  on drug trials conducted within Europe.   The charts below provide an overview of new initial clinical trial applications from January 2022 until the end of 2025. While not all of those studies will have been approved, the data provide a nice heuristic overview of drug trial volume and composition by country.   Number of drug trials per country Patients in Spain, France, Germany, Italy and – maybe surprisingly – Poland...

Fourteen funding bodies from around the world have committed to improving clinical trial registration and reporting.   The signatories include two major East Asian funders that appear to be publicly committing themselves to trial transparency for the first time: Japan Agency for Medical Research and Development National Institute of Health, Republic of Korea   The trial transparency commitments are included in the wider-ranging WHO-initiated “ Joint statement on strengthening clinical trials...

American academic organisations have significantly increased resources devoted to improving compliance with clinical trials registration and results reporting requirements, a new study  shows.   The authors note that these investments have been paralleled by a strong increase in many universities’ compliance with legal clinical trial transparency requirements. Over the course of six years, the proportion of U.S. organisations with clinical trial registration policies increased to 74%, while...